By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Actinium Pharmaceuticals, Inc. 

501 Fifth Avenue

New York City  New York  10017  U.S.A.
Phone: 646-459-4201 Fax: n/a


Company News
Actinium (ATNM.OB) Announces Initiation Of Phase II Clinical Trial Of Actimab-A In Patients Newly Diagnosed With Acute Myeloid Leukemia Over Age 60 9/27/2016 7:43:59 AM
Actinium (ATNM.OB) To Sponsor And Participate In Be The Match Walk+Run To Raise Awareness For Bone Marrow Transplant 9/26/2016 7:52:49 AM
Actinium (ATNM.OB) To Host Webinar To Provide Update On Actimab-A Phase II Clinical Trial 9/21/2016 10:38:06 AM
Actinium (ATNM.OB) To Present At Ladenburg Thalmann 2nd Annual Healthcare Conference 9/19/2016 11:39:19 AM
Actinium (ATNM.OB) Presenting At Rodman & Renshaw 18th Annual Global Investment Conference 9/13/2016 8:30:40 AM
Actinium (ATNM.OB) Presenting At The Biocentury 23rd Annual Newsmakers In The Biotech Industry Conference 9/9/2016 7:39:19 AM
Actinium (ATNM.OB) Enhances Capabilities With Hiring Of Industry And Clinical Research Veterans To Its Product Development And Clinical Development Teams 9/7/2016 9:56:55 AM
Actinium (ATNM.OB) Calls Investigator Meeting in Dallas 'Successful' 7/20/2016 5:47:25 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Initiates Pivotal Phase 3 SIERRA Trial 6/29/2016 12:21:42 PM
BIO2016: Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At BIO International Convention To Provide Updates On Actimab-A And Iomab-B Programs 6/9/2016 12:31:45 PM